Anika Therapeutics (ANIK) Tax Rate Growth (1y) (2011 - 2026)

Anika Therapeutics (ANIK) Tax Rate Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.91 Bn 88.04 Bn -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.05 Bn 20.89 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Anika Therapeutics 203.37 Mn 136.58 Mn 19.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -229.00
Dec 31, 2025 5,550.00
Sep 30, 2025 -70,794.00
Jun 30, 2025 9,149.00
Mar 31, 2025 -34.00
Dec 31, 2024 -23,492.00
Sep 30, 2024 66,059.00
Jun 30, 2024 -11,891.00
Mar 31, 2024 -1,610.00
Dec 31, 2023 975.00
Sep 30, 2023 -1,503.00
Jun 30, 2023 -368.00
Mar 31, 2023 -705.00
Dec 31, 2022 301.00
Sep 30, 2022 -3,377.00
Jun 30, 2022 -1,502.00
Mar 31, 2022 15,448.00
Dec 31, 2021 5,683.00
Sep 30, 2021 3,506.00
Jun 30, 2021 787.00